Economics ❯ Healthcare Economics

Drug Pricing Models

Market Dynamics International Pricing International Comparisons Consumer Behavior Most-Favored-Nation Pricing International Price Comparison Rebate Systems Market Competition Market Impact Consumer Impact Market Comparisons Market Transparency Market Analysis Public Health Funding Insurance Coverage Market Regulation Most Favored Nation Pricing Most Favored Nation Policy Consumer Savings Cost Savings

TrumpRX.gov Launches With 40+ Lower-Priced Drugs as Companies Announce Cuts

The push leans on 'most favored nation' pricing to align U.S. costs with rates in other wealthy countries.

AbbVie Strikes Trump Drug-Pricing Deal, Pledges $100 Billion, Wins 3-Year Tariff Reprieve

White House Adds 9 Pharma Deals, Extending Drug-Price Pacts to 14 Manufacturers

TrumpRx–Pfizer Drug-Price Deal Leaves Key Details Unclear